Colitis Latest Advances

Find the Latest Research About Colitis

Last Updated: 06/30/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 89727 publications

Prenatal Exposure to Acid-Suppressive Medications and Incident Risk of Inflammatory Bowel Disease in Children.

Prenatal Exposure to Acid-Suppressive Medications and Incident Risk of Inflammatory Bowel Disease in Children.

Journal: JAMA network open

Published: June 24, 2026

Physcion-Loaded, Folic Acid-Conjugated DSPE-PEG Liposomes for Targeted Therapy of Ulcerative Colitis.

Physcion-Loaded, Folic Acid-Conjugated DSPE-PEG Liposomes for Targeted Therapy of Ulcerative Colitis.

Journal: Journal of drug targeting

Published: June 24, 2026

The protein tyrosine phosphatase CD45 promotes PMN transepithelial migration, antimicrobial function and colonic mucosal repair.

The protein tyrosine phosphatase CD45 promotes PMN transepithelial migration, antimicrobial function and colonic mucosal repair.

Journal: JCI insight

Published: June 23, 2026

Corrigendum to "Copper chelator ammonium tetrathiomolybdate ameliorates the visceral hypersensitivity in dextran sulfate sodium-induced colitis mice".

Corrigendum to "Copper chelator ammonium tetrathiomolybdate ameliorates the visceral hypersensitivity in dextran sulfate sodium-induced colitis mice".

Journal: Molecular pain

Published: June 23, 2026

Postbiotic extracellular vesicles: the next generation of natural products for ulcerative colitis.

Postbiotic extracellular vesicles: the next generation of natural products for ulcerative colitis.

Journal: Natural product research

Published: June 23, 2026

Correction to:NMI Promotes Pro-Inflammatory Macrophage Polarization and Exacerbates Ulcerative Colitis.

Correction to:NMI Promotes Pro-Inflammatory Macrophage Polarization and Exacerbates Ulcerative Colitis.

Journal: Inflammation

Published: June 23, 2026

Mechanisms by which proline reductase of Clostridioides difficile promotes efficient metabolism and disease progression in vivo.

Mechanisms by which proline reductase of Clostridioides difficile promotes efficient metabolism and disease progression in vivo.

Journal: mBio

Published: June 22, 2026

The co-localizing Zorya II, Druantia III, and ARMADA II defense systems on O-island 172 confer synergistic anti-phage defense in enterohemorrhagic Escherichia coli.

The co-localizing Zorya II, Druantia III, and ARMADA II defense systems on O-island 172 confer synergistic anti-phage defense in enterohemorrhagic Escherichia coli.

Journal: mBio

Published: June 22, 2026

Inhibition of Aryl hydrocarbon receptor Interleukin-22 signaling and worsening of intestinal inflammation by Sutterella species.

Inhibition of Aryl hydrocarbon receptor Interleukin-22 signaling and worsening of intestinal inflammation by Sutterella species.

Journal: Gut microbes

Published: June 22, 2026

Novel mouse models for perianal fistulizing Crohn's disease reveal therapeutic value of interferon-γ antagonists.

Novel mouse models for perianal fistulizing Crohn's disease reveal therapeutic value of interferon-γ antagonists.

Journal: bioRxiv : the preprint server for biology

Published: June 22, 2026

A patent review of GPR84 receptor antagonists (2020-present).

A patent review of GPR84 receptor antagonists (2020-present).

Journal: Expert opinion on therapeutic patents

Published: June 22, 2026

Corrigendum to "Preparation of colon-targeted pellets loaded with filgotinib/berberine hydrochloride and Their application in ulcerative colitis therapy" [International Journal of Pharmaceutics: X 2025 (10) 100415].

Corrigendum to "Preparation of colon-targeted pellets loaded with filgotinib/berberine hydrochloride and Their application in ulcerative colitis therapy" [International Journal of Pharmaceutics: X 2025 (10) 100415].

Journal: International journal of pharmaceutics: X

Published: June 22, 2026

Showing 1-12 of 89,727

Last Updated: 06/30/2026